MX9306031A - HIV-1 SENSITIZING INHIBITORS '' SENSITIZES HIV-INFECTED INDIVIDUALS TO 'NON-NUCLEOSID DRUGS TO TREAT HIV'. - Google Patents

HIV-1 SENSITIZING INHIBITORS '' SENSITIZES HIV-INFECTED INDIVIDUALS TO 'NON-NUCLEOSID DRUGS TO TREAT HIV'.

Info

Publication number
MX9306031A
MX9306031A MX9306031A MX9306031A MX9306031A MX 9306031 A MX9306031 A MX 9306031A MX 9306031 A MX9306031 A MX 9306031A MX 9306031 A MX9306031 A MX 9306031A MX 9306031 A MX9306031 A MX 9306031A
Authority
MX
Mexico
Prior art keywords
hiv
sensitizing
nucleosid
sensitizes
inhibitors
Prior art date
Application number
MX9306031A
Other languages
Spanish (es)
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9306031A publication Critical patent/MX9306031A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El uso de un FARMACO NO NUCLEOSIDO PARA TRATAR HIV para preparar un medicamento para tratar a los individuos HIV positivos que tienen cepas de HIV que presentan mayor sensibilidad al mismo debido a la administración de un INHIBIDOR SENSIBILIZANTE DE HIV-1.The use of a NON-NUCLEOSIDE PHARMACEUTICAL TO TREAT HIV to prepare a medicine to treat HIV-positive individuals who have strains of HIV that are more sensitive to it due to the administration of an HIV-1 SENSITIZING INHIBITOR.

MX9306031A 1992-10-28 1993-09-29 HIV-1 SENSITIZING INHIBITORS '' SENSITIZES HIV-INFECTED INDIVIDUALS TO 'NON-NUCLEOSID DRUGS TO TREAT HIV'. MX9306031A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12

Publications (1)

Publication Number Publication Date
MX9306031A true MX9306031A (en) 1994-04-29

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306031A MX9306031A (en) 1992-10-28 1993-09-29 HIV-1 SENSITIZING INHIBITORS '' SENSITIZES HIV-INFECTED INDIVIDUALS TO 'NON-NUCLEOSID DRUGS TO TREAT HIV'.

Country Status (12)

Country Link
EP (1) EP0666744A1 (en)
JP (1) JPH08502745A (en)
KR (1) KR950703958A (en)
AU (1) AU4848293A (en)
CA (1) CA2145545A1 (en)
CZ (1) CZ69695A3 (en)
FI (1) FI952018A0 (en)
HU (1) HUT72050A (en)
MX (1) MX9306031A (en)
NO (1) NO951608L (en)
PL (1) PL308551A1 (en)
WO (1) WO1994009781A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
JP4544820B2 (en) 2001-03-09 2010-09-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Heterocyclic compounds
BR0314059A (en) 2002-09-06 2005-07-05 Janssen Pharmaceutica Nv Heterocyclic compounds
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
TW201307347A (en) 2010-11-01 2013-02-16 Arqule Inc Substituted benzo-imidazo-pyrido-diazepine compounds

Also Published As

Publication number Publication date
FI952018A (en) 1995-04-27
FI952018A0 (en) 1995-04-27
WO1994009781A1 (en) 1994-05-11
HUT72050A (en) 1996-03-28
CZ69695A3 (en) 1995-12-13
NO951608L (en) 1995-06-28
AU4848293A (en) 1994-05-24
HU9501218D0 (en) 1995-06-28
CA2145545A1 (en) 1994-05-11
PL308551A1 (en) 1995-08-21
JPH08502745A (en) 1996-03-26
EP0666744A1 (en) 1995-08-16
NO951608D0 (en) 1995-04-27
KR950703958A (en) 1995-11-17

Similar Documents

Publication Publication Date Title
MX9204454A (en) THIOUREA DERIVATIVES TO INHIBIT THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS AND THE PHARMACEUTICAL FORMULATE CONTAINING THEM.
AR004700A1 (en) 1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
ES2188782T3 (en) PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACINE.
FI940787A (en) Dosage form for short-term administration of the drug
ES2083668T5 (en) ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS.
ES2054860T5 (en) DERIVATIVES OF 9-HALOGEN- (Z) -PROSTAGLANDINAS, PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
AR008878A1 (en) VITRONECTIN RECEPTOR ANTAGONISTS, A METHOD FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
AR012294A1 (en) DERIVATIVES OF SULFONAMIDE, A PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A MEDICINAL PRODUCT.
ES2098920T3 (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF NICOTINE DEPENDENCE.
KR960700721A (en) USE OF LAMOTRIGINE FOR TREATING AIDS-RELATED NEURAL DISORDERS
DK0574255T3 (en) New derivatives of non-steroidal anti-inflammatory analgesic and / or antipyretic drugs, their use and pharmaceutical formulations containing them.
ATE213633T1 (en) MEDICINAL CONTAINING LAMOTRIGINE
ES2128043T3 (en) USE OF BIS (AMIDINOBENCIMIDAZOLES) IN THE PREPARATION OF A MEDICINAL PRODUCT TO INHIBIT RETROVIRAL INTEGRASE.
MX9306031A (en) HIV-1 SENSITIZING INHIBITORS '' SENSITIZES HIV-INFECTED INDIVIDUALS TO 'NON-NUCLEOSID DRUGS TO TREAT HIV'.
MX9303572A (en) PROTEASE INHIBITORS OF THE HUMAN IMMUNODEFICIENCY SYNDROME, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
MX9308025A (en) HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR SUPREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
ES2094834T3 (en) DEVICE FOR WASHING, FOR THERAPEUTIC OR HYGIENE PURPOSES, OF INTERNAL HUMAN OR ANIMAL DUCTS.
ES2171459T3 (en) NASAL ADMINISTRATION POWDER FOR PEPTIDIC PHARMACO OR PROTEINACEO.
MX9306607A (en) TILIDINE DINDIHYDROGEN-OTORPHOSPHATE, PROCEDURE FOR ITS OBTAINING AND THE PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT.
KR890009401A (en) How to suppress the virus
BR0107881A (en) Fsh use infertility treatment
ES2043943T3 (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH CENTRAL ANALGESIC ACTIVITY.
NO981898D0 (en) Use of flupirtine for the prevention and treatment of diseases associated with damage to the hematophotic cell system
ES2065855B1 (en) PROCEDURE FOR THE PREPARATION OF NEW DEOXIAZAPHOSPHOLIPIDIC DERIVATIVES WITH INHIBITING ACTION OF THE PHOSFOLIPASE A2, NEW DERIVATIVES DEOXIAZAPHOSPHOLIPIDICES OBTAINED AND USE OF THEM.
HUP0100365A2 (en) Combination therapy for the treatment of aids